secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gossamer Bio, Inc. (GOSS)
CIK:        0001728117
Form:       8-K
Filed at:   2026-04-09T23:59:59+00:00
Accession:  0001728117-26-000022
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Gossamer Bio receives Nasdaq bid price deficiency notice; 180 days to cure
--------------------------------------------------------------------------

- Nasdaq notified Gossamer on April 8, 2026 that stock bid price <$1.00 for 30 consecutive business days (Feb 24 – Apr 7, 2026).
- Company has 180 calendar days, until Oct 5, 2026, to regain compliance by closing bid >=$1.00 for 10 consecutive business days.
- If not cured by Oct 5, may transfer to Nasdaq Capital Market for additional 180-day compliance period if eligible.
- Company will monitor price and consider options including reverse stock split if needed.
- No assurance of regaining compliance; potential delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728117/000172811726000022/0001728117-26-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728117/000172811726000022/goss-20260408.htm
  HTML page:      https://secwatch.observer/filing/0001728117-26-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer